You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 131 No. 11, November 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Does Intraoperative Blood Loss Affect Antibiotic Serum and Tissue Concentrations?

Sandra M. Swoboda, RN, MSN; Cindy Merz, MT; John Kostuik, MD; Brian Trentler; Pamela A. Lipsett, MD

Arch Surg. 1996;131(11):1165-1172.


Abstract

Objective
To determine the effect of intraoperative blood loss on prophylactic cefazolin and gentamicin serum and tissue concentrations.

Design
A prospective study of elective spinal instrumentation surgical procedures with an expected large blood loss.

Setting
Tertiary care, inner-city university hospital.

Patients
Eleven adult patients who underwent an elective surgical procedure that involved spinal instrumentation.

Intervention
Standard perioperative administration of a combination of cefazolin and gentamicin. Serum and tissue samples were obtained consecutively throughout the surgical procedure.

Main Outcome Measures
The effect of intraoperative blood loss on serum and tissue cefazolin and gentamicin concentrations and their pharmacokinetics.

Results
At the time of the incision, serum cefazolin concentrations were greater than tissue concentrations (P=.07). A mean dose of 1.8-mg/kg gentamicin yielded low or nontherapeutic serum and tissue gentamicin concentrations. Cefazolin and gentamicin were eliminated from the tissue compartment slower than from the serum compartment (P<.03), while the half-life of cefazolin was significantly (P=.06) longer in the tissue compartment. The volume of distribution of cefazolin was normal (ie, 12.5 L), while the volume of distribution of gentamicin was 5-fold greater than expected. At 60 minutes after the incision, blood loss correlated with cefazolin tissue concentrations (r=–0.66, P=.05). Blood loss correlated with the change in tissue antibiotic concentrations for cefazolin (r=0.73, P=.04). In addition, the clearance of gentamicin from the tissues correlated with blood loss (r=0.82, P=.01).

Conclusions
Based on measured pharmacokinetic values, additional doses of cefazolin should be administered when the operation exceeds 3 hours and blood loss is greater than 1500 mL. Doses of gentamicin greater than 1.8 mg/kg should be administered more than 30 minutes prior to the surgical incision.

Arch Surg. 1996;131:1165-1172



Author Affiliations

From the Department of Surgery, The Johns Hopkins University Schools of Medicine and Nursing (Ms Swoboda); the Departments of Pathology (Ms Merz) and Pharmacy (Mr Trentler), The John Hopkins Hospital; and the Departments of Orthopedics (Dr Kostuik) and Surgery (Dr Lipsett), The Johns Hopkins University School of Medicine, Baltimore, Md.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prophylactic Antibiotics in Orthopaedic Surgery
Prokuski
J Am Acad Orthop Surg 2008;16:283-293.
ABSTRACT | FULL TEXT  

End-of-procedure cefazolin concentrations after administration for prevention of surgical-site infection
Koopman et al.
Am J Health Syst Pharm 2007;64:1927-1934.
ABSTRACT | FULL TEXT  

Implementing 1-Dose Antibiotic Prophylaxis for Prevention of Surgical Site Infection--Invited Critique
Makary
Arch Surg 2006;141:1114-1114.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.